Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases
{{output}}
Immunometabolism is central to chronic inflammatory diseases, with metabolic reprogramming including dysregulated glycolysis, mitochondrial dysfunction, and excessive ROS production driving pathology in conditions like IBD, rheumatoid arthritis, and psoriasis.... ...
